首页> 外国专利> Ameliorating immunological rejection of allograft

Ameliorating immunological rejection of allograft

机译:改善同种异体移植的免疫排斥

摘要

The invention provides a method to prevent or ameliorate hyperacute or acute rejection of a human donor organ transplanted to a human recipient. Hyperacute rejection would normally occur after a human subject receives a transplanted human organ against which the subject has preformed anti- HLA antibodies. Acute rejection occurs when the recipient of a human organ forms antibodies against that organ after transplant. The invention method comprises passing the plasma of the recipient over a sterile and pyrogen-free column coupled to anti-human immunoglobulin antibodies which bind to and remove a significant portion of the immunoglobulin from the subject's plasma.
机译:本发明提供了一种预防或改善移植到人类受体的人类供体器官的超急性或急性排斥的方法。超急性排斥反应通常会在人类受试者接受已针对其形成抗HLA抗体的移植人体器官后发生。当人体器官的受体在移植后形成针对该器官的抗体时,就会发生急性排斥反应。本发明的方法包括使受体的血浆通过与抗人免疫球蛋白抗体偶联的无菌且无热原的柱,所述抗人免疫球蛋白抗体结合并从受试者的血浆中去除大部分的免疫球蛋白。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号